Evidence map›Paper›PMID 40330358›Full record

ArticleCureus2025

Quantitative Sensory Testing in a Girl With Tangier Disease: A Case Report.

Edicson Ruiz-Ospina, Fernando Ortiz-Corredor, Sandra Milena Castellar-Leones, Javier Rubio Delgado-Martinez

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Tangier Disease.Current atherosclerosis reports · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Edicson Ruiz-OspinaRehabilitation Medicine, Universidad Nacional de Colombia, Bogotá, COL.
Fernando Ortiz-CorredorRehabilitation Medicine, Universidad Nacional de Colombia, Bogotá, COL.
Sandra Milena Castellar-LeonesRehabilitation Medicine, Universidad Nacional de Colombia, Bogotá, COL.
Javier Rubio Delgado-MartinezRehabilitation Medicine, Universidad Nacional de Colombia, San Juan de Pasto, COL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tangier disease is a rare genetic disorder caused by a deficiency in the ABCA1 gene, resulting in impaired metabolism of high-density lipoprotein (HDL) cholesterol. This disorder affects multiple organs, including the nervous system, and presents with a range of neurological symptoms. The primary neurological manifestation is peripheral nerve dysfunction, characterized by numbness, tingling, and weakness in the extremities. Autonomic dysfunction may also occur, causing bowel and bladder abnormalities. Cholesterol accumulation in nerve tissues is believed to be responsible for these symptoms. Research has shown that patients with Tangier disease commonly exhibit electrophysiological characteristics indicative of large fiber neuropathy. Small fiber neuropathy, a condition involving damage to small, unmyelinated nerve fibers, is not typically considered a defining feature of the disease. However, diagnostic methods such as quantitative sensory studies, which could help detect small fiber neuropathy, are often overlooked in the literature. In many cases, the diagnostic approach to neuropathy halts when electrodiagnostic studies return normal results, often disregarding the possibility of an underlying small fiber neuropathy. This may contribute to the underrecognition of small fiber neuropathy in Tangier disease.

Indexed as

childrenneuropathic disordersquantitative sensory testsmall fiber neuropathytangier's

Identifiers

PMID40330358
PMCPMC12050346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.